Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FP9R1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,828
Award facts
- Contract value 100% obligated
- $16,827.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,827.96 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections in 2 mL formulations. This is a firm fixed-price delivery order with no set-aside designation, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor specializing in comprehensive medical procurement for military and veteran healthcare systems. The company's extensive portfolio of federal contracts reflects its capacity to supply a wide range of pharmaceutical products across multiple therapeutic domains on a competitive basis. Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis, and this procurement supports the Defense Health Agency and other military healthcare systems' medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FP9R1?
SPE2DB25FP9R1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FP9R1 worth?
The government has obligated $16,828 on SPE2DB25FP9R1.
Is contract SPE2DB25FP9R1 an order under another contract?
Yes. SPE2DB25FP9R1 is a delivery order under SPE2DB20D3103, an indefinite delivery contract.
Was contract SPE2DB25FP9R1 competed?
The extent of competition for SPE2DB25FP9R1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award